Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traditional vs. Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction
NCT03818932Phase 3Completed
- Sponsor
- Henry Ford Health
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of celecoxib, ketorolac, gabapentin, acetaminophen and diazepam in postoperative pain (2 arms), sponsored by Henry Ford Health. Primary endpoints: Pain Levels Using the Visual Analog Scale at 10 days and Patient-Reported Outcomes Measurement Information System at 10 days. Started Jan 2019; status: completed.
02
Drugs
celecoxibketorolacgabapentinacetaminophendiazepam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03818932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818932.